Wound Care News and Research

RSS

National Institute for Health Research funds for wound care research

The University of York's Department of Health Sciences and NHS Leeds Community Healthcare have been awarded a £1.75m grant from the National Institute for Health Research to carry out a study into complex wounds.

17 Sep 2009

OCLS' partnership with V&M Industries to market Microcyn-based skin and wound care products

Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat infections in chronic and acute wounds, announced today it has entered into a new strategic partnership with V&M Industries, Inc. for non-exclusive rights to market Microcyn-based skin and wound care over-the-counter products in the United States and Canada while providing Oculus with a significant percentage of those revenues.

16 Sep 2009

NYSDOH blocks U.S.-Egypt study of ozone-based medical therapies for diabetic skin ulcers

A study exploring the healing of diabetic skin ulcers using topical oxygen/ozone gas mixtures could not proceed to completion and was now abandoned, according to Ozonics International, LLC, a veteran-owned biotechnology company engaged in the research and development of ozone-based medical therapies.

15 Sep 2009

HemCon Medical Technologies and Zimmer Dental sign distribution agreement

HemCon Medical Technologies, Inc. (“HemCon”), a leading developer of advanced medical products, is proud to announce the signing of an exclusive global distribution agreement with Zimmer Dental Inc., a leading provider of dental oral rehabilitation products and a subsidiary of Zimmer Holdings, Inc.

15 Sep 2009

Wake Pharma to present clinical evidence in the treatment of wounds using Wound-Be-Gone at SAWC

Wake Pharma US announced today that clinical evidence in the treatment of wounds using Wound-Be-Gone® will be presented at the fall Society for Advance Wound Care Conference. The SAWC is being held in Washington, DC from September 16-18, 2009. The clinical evidence and data will be presented through posters on display during the meeting.

15 Sep 2009

Misonix receives donation from anonoymous patient to buy SonicOne ultrasonic wound care system

Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has announced that a patient, who wishes to remain anonymous, donated the majority of the funds necessary for Christus St. Vincent Medical Center, Santa Fe, NM, to purchase a SonicOne(R) Ultrasonic Wound Cleansing and Debridement System. The System was shipped and installed during the second half of August 2009.

15 Sep 2009

B. Braun Medical to showcase its Prontosan Wound Irrigation Solution at the SAWC Fall Event

B. Braun Medical Inc. (B. Braun) said today healthcare professionals can now place orders for Prontosan(R) Wound Irrigation Solution and Gel with PHMB (Polyhexanide), a solution used for cleaning wounds as well as moistening and lubricating absorbent wound dressings.

From B. Braun Melsungen AG 14 Sep 2009

Dresner Partners advises CCHHS in its partnership with HHG

Dresner Partners, a FINRA-registered, middle-market investment bank, and IMAP member firm, announced today that it advised Care Collaborative Home Health Services, Inc. (CCHHS) in its recent strategic partnership with Home Health Group, LLC (HHG), a holding company focused on investments in the home health industry.

14 Sep 2009

Restated 2008 and 2009 financial results released by The Center for Wound Healing

The Center for Wound Healing, Inc. (OTCBB:CFWH), a leading operator of comprehensive wound care treatment centers that offer hyperbaric oxygen therapy as well as other advanced wound care treatment modalities, today announced that the Company’s consolidated financial statements for the quarter ended March 31, 2008 and for the year ended June 30, 2008 need to be restated as described below, and that investors should no longer rely upon those consolidated financial statements. The Company will file an amendment to the 2008 Form 10-QSB and 2008 Form 10-KSB to restate the 2008 Financial Statements as soon as practicable.

11 Sep 2009

Pergamum to develop Karolinska dermatology and wound healing companies

Pergamum AB has announced its formation; Pergamum will commercialize the Karolinska Development dermatology and wound healing interests, and create a broad-based therapeutic company in its focus areas.

11 Sep 2009

ThermoGenesis releases results for fourth quarter and fiscal year 2009

ThermoGenesis Corp. , a leading supplier of innovative products for processing and storing adult stem cells, today reported results for the fourth quarter and all of fiscal 2009.

10 Sep 2009

MHLW to grant regulatory approval for KCI to enter Japan market

Kinetic Concepts, Inc. (NYSE: KCI) announced today that it has been informed by the Pharmaceutical and Medical Devices Agency (PMDA) in Japan that in October the Ministry of Health, Labor and Welfare (MHLW) will grant regulatory approval for KCI to begin market development activities in Japan for its innovative V.A.C.® Therapy product.

9 Sep 2009

Bloodstream infections can be avoided with a daily scrub solution bath

Giving critically ill hospital patients a daily bath with a mild, soapy solution of the same antibacterial agent used by surgeons to "scrub in" before an operation can dramatically cut down, by as much as 73 percent, the number of patients who develop potentially deadly bloodstream infections, according to a new study by patient safety experts at The Johns Hopkins Hospital and five other institutions.

5 Sep 2009

Kane Biotech announces Harvard Medical School's research publication on its DispersinB product

Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms is pleased to announce a recent research publication by Harvard Medical School on their finding of DispersinB® enzyme specific substrate in Acinetobacter baumannii (A. baumannii).

3 Sep 2009

Third-quarter fiscal 2009 results announced by Synovis Life Technologies

Synovis Life Technologies Reports Record Revenue Of $15 Million For The Third Quarter Of Fiscal 2009

2 Sep 2009

Misonix commences direct to hospital sales of its SonaStar Ultrasonic Surgical Aspirator in the US

Misonix, Inc., (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, today announced the second expansion of its direct sales channel for the United States, which was first disclosed in June 2008.

2 Sep 2009

Medical journal article highlights the challenges faced by healthcare providers for treating patients with non-healing wounds

Cardium Therapeutics today reported that a recent medical journal article highlights the challenges facing healthcare providers with respect to finding optimal treatments for patients with non-healing wounds.

28 Aug 2009

Stemedica unveils two of its latest scientific discoveries at the 2009 World Stem Cell Summit

Stemedica Cell Technologies , Inc., ("Stemedica"), a world leader in stem cell research and manufacturing (a licensed manufacturer of clinical grade biological products as licensed by the State of California Food and Drug Branch) continues to advance the stem cell industry with the presentation of two of its latest scientific discoveries at the 2009 World Stem Cell Summit.

27 Aug 2009

DermaStream continuous streaming therapy for healing bedsores and chronic ulcers

More than six million people in the U.S. suffer from persistent wounds -- open sores that never seem to heal or, once apparently healed, return with a vengeance. The bedridden elderly and infirm are prone to painful and dangerous pressure ulcers, and diabetics are susceptible to wounds caused by a lack of blood flow to the extremities.

27 Aug 2009

Bederra Corporation's six-month financial statements show an operating loss

Bederra Corporation (PINKSHEETS: BEDA), a Houston, Texas based diversified medical services provider, recently published its six months results on www.pinksheets.com.

26 Aug 2009

Wound Care News and Research

National Institute for Health Research funds for wound care research

OCLS' partnership with V&M Industries to market Microcyn-based skin and wound care products

NYSDOH blocks U.S.-Egypt study of ozone-based medical therapies for diabetic skin ulcers

HemCon Medical Technologies and Zimmer Dental sign distribution agreement

Wake Pharma to present clinical evidence in the treatment of wounds using Wound-Be-Gone at SAWC

Misonix receives donation from anonoymous patient to buy SonicOne ultrasonic wound care system

B. Braun Medical to showcase its Prontosan Wound Irrigation Solution at the SAWC Fall Event

Dresner Partners advises CCHHS in its partnership with HHG

Restated 2008 and 2009 financial results released by The Center for Wound Healing

Pergamum to develop Karolinska dermatology and wound healing companies

ThermoGenesis releases results for fourth quarter and fiscal year 2009

MHLW to grant regulatory approval for KCI to enter Japan market

Bloodstream infections can be avoided with a daily scrub solution bath

Kane Biotech announces Harvard Medical School's research publication on its DispersinB product

Third-quarter fiscal 2009 results announced by Synovis Life Technologies

Misonix commences direct to hospital sales of its SonaStar Ultrasonic Surgical Aspirator in the US

Medical journal article highlights the challenges faced by healthcare providers for treating patients with non-healing wounds

Stemedica unveils two of its latest scientific discoveries at the 2009 World Stem Cell Summit

DermaStream continuous streaming therapy for healing bedsores and chronic ulcers

Bederra Corporation's six-month financial statements show an operating loss

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News